Lehmann-Che, J., Hamy, A., Porcher, R., Barritault, M., Bouhidel, F., Habuellelah, H., . . . Bertheau, P. (2013). Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. BioMed Central.
Chicago ZitierstilLehmann-Che, Jacqueline, et al. Molecular Apocrine Breast Cancers Are Aggressive Estrogen Receptor Negative Tumors Overexpressing Either HER2 or GCDFP15. BioMed Central, 2013.
MLA ZitierstilLehmann-Che, Jacqueline, et al. Molecular Apocrine Breast Cancers Are Aggressive Estrogen Receptor Negative Tumors Overexpressing Either HER2 or GCDFP15. BioMed Central, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.